Interaction of Motivation and Psychiatric Symptoms on Substance Abuse Outcomes in Sober Living Houses

Overview

Journal Subst Use Misuse

Publisher Informa Healthcare

Date 2014 Oct 8

PMID 25290664

Citations 14

Authors

Douglas L Polcin

Rachael A Korcha

Jason C Bond

Affiliations

Soon will be listed here.

Abstract

Background: Studies show residents of sober living recovery houses (SLHs) make improvements in a variety of areas including alcohol and drug use, arrests, and employment. Longitudinal measures of motivation (assessed as costs and benefits of continuing sobriety) have been shown to be associated with alcohol and drug outcomes in SLHs. However, how motivation interacts with other potentially important factors, such as psychiatric severity, is unclear.

Objective: The present study aimed to assess how perceived costs and benefits of sobriety among residents of SLHs differed by psychiatric severity. The study also aimed to assess how costs and benefits interacted with psychiatric severity to influence outcome.

Methods: Two hundred forty-five residents of SLHs were assessed at baseline and 6, 12, and 18 months.

Results: High psychiatric severity was associated with higher severity of alcohol and drug problems and higher perceived costs of sobriety at all data collection time points. Perceived costs and benefits of sobriety were strong predictors of alcohol and drug problems for participants with low psychiatric severity. Perceived costs, but not perceived benefits, predicted outcomes for residents with high psychiatric severity. CONCLUSIONS/IMPORTANCE: High psychiatric severity is a serious impediment for some residents in SLHs. These individuals perceive sobriety as difficult and that perception is associated with worse outcome. Finding ways to decrease perceived costs and challenges to sustained sobriety among these individuals is essential as is collaboration with local mental health services. SLHs should consider whether additional onsite services or modifications of SLH operations might help this population.

Citing Articles

Reasons for choosing sober living houses and their associations with substance use recovery outcomes.

Mahoney E, Subbaraman M, Mericle A, Polcin D Addict Behav Rep. 2024; 20:100557.

PMID: 39027409 PMC: 11252607. DOI: 10.1016/j.abrep.2024.100557.

Moving Social Model Recovery Forward: Recent Research on Sober Living Houses.

Polcin D, Mericle A, Braucht G, Wittman F Alcohol Treat Q. 2023; 41(2):173-186.

PMID: 37125214 PMC: 10139742. DOI: 10.1080/07347324.2023.2167528.

Do neighborhood characteristics of sober living houses impact recovery outcomes? A multilevel analysis of observational data from Los Angeles County.

Mahoney E, Karriker-Jaffe K, Mericle A, Patterson D, Polcin D, Subbaraman M Health Place. 2022; 79:102951.

PMID: 36535073 PMC: 9928842. DOI: 10.1016/j.healthplace.2022.102951.

Measuring Architecture in Recovery Homes: Recovery Home Architecture Scale.

Polcin D, Mahoney E, Witbrodt J, Mericle A, Subbaraman M, Wittman F Subst Use Misuse. 2022; 58(1):103-110.

PMID: 36437776 PMC: 10064876. DOI: 10.1080/10826084.2022.2148484.

Recovery Home Environment Characteristics Associated with Recovery Capital.

Polcin D, Mahoney E, Witbrodt J, Mericle A J Drug Issues. 2021; 51(2):253-267.

PMID: 34650312 PMC: 8514142. DOI: 10.1177/0022042620978393.

References

Havassy B, Alvidrez J, Owen K . Comparisons of patients with comorbid psychiatric and substance use disorders: implications for treatment and service delivery. Am J Psychiatry. 2004; 161(1):139-45. DOI: 10.1176/appi.ajp.161.1.139. View

Broome K, Flynn P, SIMPSON D . Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs. Health Serv Res. 1999; 34(3):791-806. PMC: 1089038. View

Ritsher J, McKellar J, Finney J, Otilingam P, Moos R . Psychiatric comorbidity, continuing care and mutual help as predictors of five-year remission from substance use disorders. J Stud Alcohol. 2003; 63(6):709-15. DOI: 10.15288/jsa.2002.63.709. View

Zhang A, Harmon J, Werkner J, McCormick R . Impacts of motivation for change on the severity of alcohol use by patients with severe and persistent mental illness. J Stud Alcohol. 2004; 65(3):392-7. DOI: 10.15288/jsa.2004.65.392. View

Polcin D, Korcha R, Bond J, Galloway G . Eighteen Month Outcomes for Clients Receiving Combined Outpatient Treatment and Sober Living Houses. J Subst Use. 2011; 15(5):352-366. PMC: 3008818. DOI: 10.3109/14659890903531279. View

Wittman F, Polcin D . The Evolution of Peer Run Sober Housing as a Recovery Resource for California Communities. Int J Self Help Self Care. 2014; 8(2):157-187. PMC: 4248351. DOI: 10.2190/SH.8.2.c. View

DiClemente C, Schlundt D, Gemmell L . Readiness and stages of change in addiction treatment. Am J Addict. 2004; 13(2):103-19. DOI: 10.1080/10550490490435777. View

McLellan A, Kushner H, Metzger D, Peters R, Smith I, Grissom G . The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat. 1992; 9(3):199-213. DOI: 10.1016/0740-5472(92)90062-s. View

Glasner-Edwards S, Mooney L, Marinelli-Casey P, Hillhouse M, Ang A, Rawson R . Psychopathology in methamphetamine-dependent adults 3 years after treatment. Drug Alcohol Rev. 2010; 29(1):12-20. PMC: 3772133. DOI: 10.1111/j.1465-3362.2009.00081.x. View

10.

Polcin D, Henderson D . A clean and sober place to live: philosophy, structure, and purported therapeutic factors in sober living houses. J Psychoactive Drugs. 2008; 40(2):153-9. PMC: 2556949. DOI: 10.1080/02791072.2008.10400625. View

11.

Polcin D, Bond J, Korcha R, Nayak M, Galloway G, Evans K . Randomized trial of intensive motivational interviewing for methamphetamine dependence. J Addict Dis. 2014; 33(3):253-65. PMC: 4224618. DOI: 10.1080/10550887.2014.950029. View

12.

Carey K . Substance use reduction in the context of outpatient psychiatric treatment: a collaborative, motivational, harm reduction approach. Community Ment Health J. 1996; 32(3):291-306; discussion 307-10. DOI: 10.1007/BF02249430. View

13.

Polcin D, Henderson D, Trocki K, Evans K, Wittman F . Community Context of Sober Living Houses. Addict Res Theory. 2014; 20(6):480-491. PMC: 3902663. DOI: 10.3109/16066359.2012.665967. View

14.

Majer J, Jason L, North C, Ferrari J, Porter N, Olson B . A longitudinal analysis of psychiatric severity upon outcomes among substance abusers residing in self-help settings. Am J Community Psychol. 2008; 42(1-2):145-53. PMC: 2845152. DOI: 10.1007/s10464-008-9190-z. View

15.

. Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. Project MATCH Research Group. J Stud Alcohol. 1998; 59(6):631-9. DOI: 10.15288/jsa.1998.59.631. View

16.

McLellan A, Luborsky L, Woody G, OBrien C, Druley K . Predicting response to alcohol and drug abuse treatments. Role of psychiatric severity. Arch Gen Psychiatry. 1983; 40(6):620-5. DOI: 10.1001/archpsyc.1983.04390010030004. View

17.

Wu L, Pan J, Blazer D, Tai B, Brooner R, Stitzer M . The construct and measurement equivalence of cocaine and opioid dependences: a National Drug Abuse Treatment Clinical Trials Network (CTN) study. Drug Alcohol Depend. 2009; 103(3):114-23. PMC: 2721976. DOI: 10.1016/j.drugalcdep.2009.01.018. View

18.

DiClemente C, Nidecker M, Bellack A . Motivation and the stages of change among individuals with severe mental illness and substance abuse disorders. J Subst Abuse Treat. 2007; 34(1):25-35. DOI: 10.1016/j.jsat.2006.12.034. View

19.

Clark H, Power A, Le Fauve C, Lopez E . Policy and practice implications of epidemiological surveys on co-occurring mental and substance use disorders. J Subst Abuse Treat. 2007; 34(1):3-13. DOI: 10.1016/j.jsat.2006.12.032. View

20.

Korcha R, Polcin D, Bond J, Lapp W, Galloway G . Substance use and motivation: a longitudinal perspective. Am J Drug Alcohol Abuse. 2010; 37(1):48-53. PMC: 3056520. DOI: 10.3109/00952990.2010.535583. View